Autism in Three Dimensions: Using Brain Organoids to Study Potential Gene-Environment Interactions

Overview

Journal Environ Health Perspect

Date 2021 Oct 19

PMID 34665007

Citations 2

Authors

Silke Schmidt

Affiliations

Soon will be listed here.

Citing Articles

Brain organoid protocols and limitations.

Zhao H, Haddad G Front Cell Neurosci. 2024; 18:1351734.

PMID: 38572070 PMC: 10987830. DOI: 10.3389/fncel.2024.1351734.

Analysis of Gene-Environment Interactions Related to Developmental Disorders.

Nishimura Y, Kurosawa K Front Pharmacol. 2022; 13:863664.

PMID: 35370658 PMC: 8969575. DOI: 10.3389/fphar.2022.863664.

References

Ayhan F, Konopka G . Regulatory genes and pathways disrupted in autism spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2018; 89:57-64. PMC: 6249101. DOI: 10.1016/j.pnpbp.2018.08.017. View

Zimmerman A, Connors S . Neuroscience. Could autism be treated prenatally?. Science. 2014; 343(6171):620-1. DOI: 10.1126/science.1250214. View

Lancaster M, Renner M, Martin C, Wenzel D, Bicknell L, Hurles M . Cerebral organoids model human brain development and microcephaly. Nature. 2013; 501(7467):373-9. PMC: 3817409. DOI: 10.1038/nature12517. View

Chaste P, Leboyer M . Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin Neurosci. 2012; 14(3):281-92. PMC: 3513682. View

Courchesne E, Pramparo T, Gazestani V, Lombardo M, Pierce K, Lewis N . The ASD Living Biology: from cell proliferation to clinical phenotype. Mol Psychiatry. 2018; 24(1):88-107. PMC: 6309606. DOI: 10.1038/s41380-018-0056-y. View

El-Ansary A, Al-Ayadhi L . GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders. J Neuroinflammation. 2014; 11:189. PMC: 4243332. DOI: 10.1186/s12974-014-0189-0. View

Urresti J, Zhang P, Moran-Losada P, Yu N, Negraes P, Trujillo C . Cortical organoids model early brain development disrupted by 16p11.2 copy number variants in autism. Mol Psychiatry. 2021; 26(12):7560-7580. PMC: 8873019. DOI: 10.1038/s41380-021-01243-6. View

Rice D, Barone Jr S . Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect. 2000; 108 Suppl 3:511-33. PMC: 1637807. DOI: 10.1289/ehp.00108s3511. View

Lussu M, Noto A, Masili A, C Rinaldi A, Dessi A, De Angelis M . The urinary H-NMR metabolomics profile of an italian autistic children population and their unaffected siblings. Autism Res. 2017; 10(6):1058-1066. DOI: 10.1002/aur.1748. View

10.

Stolerman E, Smith B, Chaubey A, Jones J . CHD8 intragenic deletion associated with autism spectrum disorder. Eur J Med Genet. 2016; 59(4):189-94. DOI: 10.1016/j.ejmg.2016.02.010. View

11.

Brix M, Ersland L, Hugdahl K, Gruner R, Posserud M, Hammar A . "Brain MR spectroscopy in autism spectrum disorder-the GABA excitatory/inhibitory imbalance theory revisited". Front Hum Neurosci. 2015; 9:365. PMC: 4475903. DOI: 10.3389/fnhum.2015.00365. View

12.

Modafferi S, Zhong X, Kleensang A, Murata Y, Fagiani F, Pamies D . Gene-Environment Interactions in Developmental Neurotoxicity: a Case Study of Synergy between Chlorpyrifos and CHD8 Knockout in Human BrainSpheres. Environ Health Perspect. 2021; 129(7):77001. PMC: 8278985. DOI: 10.1289/EHP8580. View

13.

Gao R, Penzes P . Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders. Curr Mol Med. 2015; 15(2):146-67. PMC: 4721588. DOI: 10.2174/1566524015666150303003028. View